Increased expression of alpha-enolase in c-jun transformed rat fibroblasts without increased activation of plasminogen

被引:16
作者
Bergman, AC
Linder, C
Sakaguchi, K
StenLinder, M
Alaiya, AA
Franzen, B
Shoshan, MC
Bergman, T
Wiman, B
Auer, G
Appella, E
Jornvall, H
Linder, S
机构
[1] KAROLINSKA HOSP & INST,RADIUMHEMMETS RES LAB,DEPT PATHOL & ONCOL,S-17176 STOCKHOLM,SWEDEN
[2] NCI,CELL BIOL LAB,NIH,BETHESDA,MD 20892
[3] KAROLINSKA HOSP & INST,DEPT CLIN CHEM,DEPT PATHOL & ONCOL,S-17176 STOCKHOLM,SWEDEN
[4] KAROLINSKA HOSP & INST,UNIT CELL & MOL ANAL,DEPT PATHOL & ONCOL,S-17176 STOCKHOLM,SWEDEN
关键词
two-dimensional gel electrophoresis; mass spectrometry; cell transformation; plasminogen activation;
D O I
10.1016/S0014-5793(97)01247-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two-dimensional gel electrophoresis was used to identify polypeptides differentially expressed between normal and c-jun transformed rat fibroblasts, The level of a 49 kDa polypeptide was 3-fold elevated in c-jun transformed cells, Sequence analysis by ion trap mass spectrometry identified the polypeptide as rat alpha-enolase, Enolase functions as a cell surface receptor for plasminogen, suggesting that upregulation may increase plasminogen activation and cell surface proteolysis important for tumor growth, However, no difference was observed between normal and transformed cells in formation of plasmin, suggesting that upregulation of alpha-enolase may contribute to an increased metabolic capacity, but not to increased plasminogen activation, (C) 1997 Federation of European Biochemical Societies.
引用
收藏
页码:17 / 20
页数:4
相关论文
共 23 条
[1]  
ANDERSON NL, 1991, LARGE SCALE BIOL PRE, P17
[2]   The human ENO1 gene product (recombinant human alpha-enolase) displays characteristics required for a plasminogen binding protein [J].
Andronicos, NM ;
Ranson, M ;
Bognacki, J ;
Baker, MS .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1997, 1337 (01) :27-39
[3]   HA-RAS AUGMENTS C-JUN ACTIVITY AND STIMULATES PHOSPHORYLATION OF ITS ACTIVATION DOMAIN [J].
BINETRUY, B ;
SMEAL, T ;
KARIN, M .
NATURE, 1991, 351 (6322) :122-127
[4]  
BONDY GP, 1985, CANCER RES, V45, P6005
[5]  
BORTNER DM, 1993, CRIT REV ONCOGENESIS, V4, P137
[6]   PLASMINOGEN-ACTIVATOR AND CANCER [J].
DUFFY, MJ ;
OGRADY, P .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (05) :577-582
[7]  
FRANZEN B, 1993, ELECTROPHORESIS, V14, P382
[8]  
GARRELS JI, 1989, J BIOL CHEM, V264, P5269
[9]   Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry (Reprinted from Science, vol 255, March 6, 1992) [J].
Hunt, Donald F. ;
Henderson, Robert A. ;
Shabanowitz, Jeffrey ;
Sakaguchi, Kazuyasu ;
Michel, Hanspeter ;
Sevilir, Noelle ;
Cox, Andrea L. ;
Appella, Ettore ;
Engelhard, Victor H. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (05) :2669-2671
[10]   The metastatic phenotype-prognostic implications [J].
Lindblom, A ;
Linder, S .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1996, 24 (02) :71-96